Acelyrin Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.25
| Current Ratio | 3.25 |
| Quick Ratio | 3.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 0.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 83 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.67% in the last 52 weeks. The beta is 1.09, so Acelyrin's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -47.67% |
| 50-Day Moving Average | 2.42 |
| 200-Day Moving Average | 3.63 |
| Relative Strength Index (RSI) | 47.51 |
| Average Volume (20 Days) | 1,074,676 |
Short Selling Information
The latest short interest is 3.57 million, so 3.54% of the outstanding shares have been sold short.
| Short Interest | 3.57M |
| Short Previous Month | 3.69M |
| Short % of Shares Out | 3.54% |
| Short % of Float | 5.21% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | 250.00M |
| Gross Profit | 250.00M |
| Operating Income | 10.00M |
| Pretax Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | 10.00M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $10.00 million in cash and n/a in debt, giving a net cash position of $10.00 million.
| Cash & Cash Equivalents | 10.00M |
| Total Debt | n/a |
| Net Cash | 10.00M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.18B |
| Book Value Per Share | 495.41 |
| Working Capital | 180.00M |
Cash Flow
| Operating Cash Flow | -170.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | 4.00% |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | 4.00% |
| FCF Margin | n/a |
Dividends & Yields
Acelyrin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Acelyrin is $9.60, which is 326.67% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.60 |
| Price Target Difference | 326.67% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 29.71% |
| EPS Growth Forecast (5Y) | -29.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |